France
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 26.70 B
|
Dec. 31, 2023 | USD 107.71 | -0.06% |
|
France |
|
2 |
USD 175.35 M
|
Dec. 31, 2023 | USD 3.46 | 7.58% |
|
France |
|
3 |
USD 153.85 M
|
Dec. 31, 2023 | USD 76.53 | 1.34% |
|
France |
|
4 |
USD 77.31 M
|
Dec. 31, 2023 | USD 6.04 | 2.29% |
|
France |
|
5 |
USD 58.36 M
|
Dec. 31, 2023 | USD 26.53 | 0.03% |
|
France |
|
6 |
USD 55.36 M
|
Dec. 31, 2023 | USD 2.40 | -1.45% |
|
France |
|
7 |
USD 55.05 M
|
Dec. 31, 2023 | USD 3.58 | 3.12% |
|
France |
|
8 |
USD 43.75 M
|
Dec. 31, 2023 | USD 2.09 | 3.97% |
|
France |
|
9 |
USD 37.62 M
|
Dec. 31, 2023 | USD 0.63 | -3.60% |
|
France |
|
10 |
USD 37.34 M
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
11 |
USD 21.86 M
|
Dec. 31, 2023 | USD 5.82 | 3.14% |
|
France |
|
12 |
USD 20.75 M
|
Dec. 31, 2023 | USD 6.79 | 2.49% |
|
France |
|
13 |
USD 20.62 M
|
Dec. 31, 2023 | USD 1.64 | -0.17% |
|
France |
|
14 |
USD 17.77 M
|
March 31, 2024 | USD 17.01 | 1.06% |
|
France |
|
15 |
USD 11.07 M
|
Dec. 31, 2023 | USD 2.39 | -7.42% |
|
France |
|
16 |
USD 9.68 M
|
Dec. 31, 2023 | USD 1.42 | 2.06% |
|
France |
|
17 |
USD 9.27 M
|
Dec. 31, 2023 | USD 3.46 | -1.94% |
|
France |
The Vaccines company in France with the highest Current Liabilities is Sanofi (Paris Stock Exchange: SAN.PA) at USD 26.70 B.
The Vaccines company in France with the lowest Current Liabilities is genOway SA (Paris Stock Exchange: ALGEN.PA) at USD 9.27 M.
The top 10 Vaccines companies in France by Current Liabilities are Sanofi, Valneva SE, Vetoquinol SA, ABIVAX SA, Eurobio Scientific SA, Inventiva S.A., Nanobiotix S.A., Innate Pharma S.A., Novacyt S.A. and DBV Technologies S.A..
The bottom 10 Vaccines companies in France by Current Liabilities are genOway SA, Valbiotis SA, Aelis Farma SA, MedinCell S.A., AB Science S.A., OSE Immunotherapeutics SA, Adocia SA, DBV Technologies S.A., Novacyt S.A. and Innate Pharma S.A..